Literature DB >> 24662316

Apolipoprotein E-deficient mice are susceptible to the development of acute lung injury.

Cory M Yamashita1, Michael B Fessler, Lakshman Vasanthamohan, Joanne Lac, Jennifer Madenspacher, Lynda McCaig, Lijuan Yao, Lefeng Wang, Valeria Puntorieri, Sanjay Mehta, Jim F Lewis, Ruud A W Veldhuizen.   

Abstract

BACKGROUND: Apolipoprotein E (apoE) has been shown to play a pivotal role in the development of cardiovascular disease, attributable to its function in lipid trafficking and immune modulating properties; however, its role in modulating inflammation in the setting of acute lung injury (ALI) is unknown.
OBJECTIVE: To determine whether apoE-deficient mice (apoE-/-) are more susceptible to ALI compared to wild-type (WT) animals.
METHODS: Two independent models of ALI were employed. Firstly, WT and apoE-/- mice were randomized to acid aspiration (50 μl of 0.1 N hydrochloric acid) followed by 4 h of mechanical ventilation. Secondly, WT and apoE-/- mice were randomized to 72 h of hyperoxia exposure or room air. Thereafter, the intrinsic responses of WT and apoE-/- mice were assessed using the isolated perfused mouse lung (IPML) setup. Finally, based on elevated levels of oxidized low-density lipoprotein (oxLDL) in apoE-/-, the effect of oxLDL on lung endothelial permeability and inflammation was assessed.
RESULTS: In both in vivo models, apoE-/- mice demonstrated greater increases in lung lavage protein levels, neutrophil counts, and cytokine expression (p < 0.05) compared to WT mice. Experiments utilizing the IPML setup demonstrated no differences in intrinsic lung responses to injury between apoE-/- and WT mice, suggesting the presence of a circulating factor as being responsible for the in vivo observations. Finally, the exposure of lung endothelial cells to oxLDL resulted in increased monolayer permeability and IL-6 release compared to native (nonoxidized) LDL.
CONCLUSIONS: Our findings demonstrate a susceptibility of apoE-/- animals to ALI that may occur, in part, due to elevated levels of oxLDL.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24662316      PMCID: PMC4659709          DOI: 10.1159/000358438

Source DB:  PubMed          Journal:  Respiration        ISSN: 0025-7931            Impact factor:   3.580


  36 in total

1.  The ALIEN study: incidence and outcome of acute respiratory distress syndrome in the era of lung protective ventilation.

Authors:  Jesús Villar; Jesús Blanco; José Manuel Añón; Antonio Santos-Bouza; Lluís Blanch; Alfonso Ambrós; Francisco Gandía; Demetrio Carriedo; Fernando Mosteiro; Santiago Basaldúa; Rosa Lidia Fernández; Robert M Kacmarek
Journal:  Intensive Care Med       Date:  2011-10-14       Impact factor: 17.440

2.  Emerging therapies for treatment of acute lung injury and acute respiratory distress syndrome.

Authors:  Cory M Yamashita; James F Lewis
Journal:  Expert Opin Emerg Drugs       Date:  2012-03-06       Impact factor: 4.191

3.  Apolipoprotein E suppresses the type I inflammatory response in vivo.

Authors:  Kamilah Ali; Melissa Middleton; Ellen Puré; Daniel J Rader
Journal:  Circ Res       Date:  2005-09-22       Impact factor: 17.367

4.  The effect of tidal volume on systemic inflammation in Acid-induced lung injury.

Authors:  Melissa G Walker; Li-Juan Yao; Eric K Patterson; Mariamma G Joseph; Gediminas Cepinskas; Ruud A W Veldhuizen; James F Lewis; Cory M Yamashita
Journal:  Respiration       Date:  2011-02-09       Impact factor: 3.580

5.  Effect of mechanical ventilation on inflammatory mediators in patients with acute respiratory distress syndrome: a randomized controlled trial.

Authors:  V M Ranieri; P M Suter; C Tortorella; R De Tullio; J M Dayer; A Brienza; F Bruno; A S Slutsky
Journal:  JAMA       Date:  1999-07-07       Impact factor: 56.272

6.  Septic pulmonary microvascular endothelial cell injury: role of alveolar macrophage NADPH oxidase.

Authors:  K S Farley; L Wang; S Mehta
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2008-12-12       Impact factor: 5.464

7.  Transient increase in plasma oxidized LDL during the progression of atherosclerosis in apolipoprotein E knockout mice.

Authors:  Rina Kato; Chihiro Mori; Keiko Kitazato; Satoru Arata; Takashi Obama; Masahiro Mori; Katsuhiko Takahashi; Toshihiro Aiuchi; Tatsuya Takano; Hiroyuki Itabe
Journal:  Arterioscler Thromb Vasc Biol       Date:  2008-11-06       Impact factor: 8.311

8.  Obesity and pulmonary complications in critically injured adults.

Authors:  Lesly A Dossett; Daithi Heffernan; Michelle Lightfoot; Bryan Collier; Jose J Diaz; Robert G Sawyer; Addison K May
Journal:  Chest       Date:  2008-08-21       Impact factor: 9.410

Review 9.  Bench-to-bedside review: the role of the alveolar epithelium in the resolution of pulmonary edema in acute lung injury.

Authors:  Rachel L Zemans; Michael A Matthay
Journal:  Crit Care       Date:  2004-06-30       Impact factor: 9.097

10.  Lung-derived mediators induce cytokine production in downstream organs via an NF-κB-dependent mechanism.

Authors:  E K Patterson; L J Yao; N Ramic; J F Lewis; G Cepinskas; L McCaig; R A W Veldhuizen; C M Yamashita
Journal:  Mediators Inflamm       Date:  2013-03-27       Impact factor: 4.711

View more
  13 in total

1.  Roles of the Mevalonate Pathway and Cholesterol Trafficking in Pulmonary Host Defense.

Authors:  Kristin A Gabor; Michael B Fessler
Journal:  Curr Mol Pharmacol       Date:  2017       Impact factor: 3.339

Review 2.  A New Frontier in Immunometabolism. Cholesterol in Lung Health and Disease.

Authors:  Michael B Fessler
Journal:  Ann Am Thorac Soc       Date:  2017-11

Review 3.  Pulmonary vascular dysfunction in metabolic syndrome.

Authors:  Conor Willson; Makiko Watanabe; Atsumi Tsuji-Hosokawa; Ayako Makino
Journal:  J Physiol       Date:  2018-09-12       Impact factor: 5.182

4.  Serum apolipoprotein A-I and large high-density lipoprotein particles are positively correlated with FEV1 in atopic asthma.

Authors:  Amisha V Barochia; Maryann Kaler; Rosemarie A Cuento; Elizabeth M Gordon; Nargues A Weir; Maureen Sampson; Joseph R Fontana; Sandra MacDonald; Joel Moss; Vincent Manganiello; Alan T Remaley; Stewart J Levine
Journal:  Am J Respir Crit Care Med       Date:  2015-05-01       Impact factor: 21.405

5.  Antibody Responses to Citrullinated and Noncitrullinated Antigens in the Sputum of Subjects With Rheumatoid Arthritis and Subjects at Risk for Development of Rheumatoid Arthritis.

Authors:  M Kristen Demoruelle; Emily Bowers; Lauren J Lahey; Jeremy Sokolove; Monica Purmalek; Nickie L Seto; Michael H Weisman; Jill M Norris; Mariana J Kaplan; V Michael Holers; William H Robinson; Kevin D Deane
Journal:  Arthritis Rheumatol       Date:  2018-03-02       Impact factor: 10.995

6.  The effect of matrix metalloproteinase-3 deficiency on pulmonary surfactant in a mouse model of acute lung injury.

Authors:  Cory M Yamashita; Candice Cybulskie; Scott Milos; Yi Y Zuo; Lynda A McCaig; Ruud A W Veldhuizen
Journal:  Can J Physiol Pharmacol       Date:  2016-01-19       Impact factor: 2.273

Review 7.  Emerging Roles of Apolipoprotein E and Apolipoprotein A-I in the Pathogenesis and Treatment of Lung Disease.

Authors:  Xianglan Yao; Elizabeth M Gordon; Debbie M Figueroa; Amisha V Barochia; Stewart J Levine
Journal:  Am J Respir Cell Mol Biol       Date:  2016-08       Impact factor: 6.914

8.  Lrp1 Regulation of Pulmonary Function. Follow-Up of Human GWAS in Mice.

Authors:  Cody E Nichols; John S House; Huiling Li; James M Ward; Annah Wyss; Jason G Williams; Leesa J Deterding; Jennifer A Bradbury; Laura Miller; Darryl C Zeldin; Stephanie J London
Journal:  Am J Respir Cell Mol Biol       Date:  2021-03       Impact factor: 6.914

9.  Apolipoprotein E is a concentration-dependent pulmonary danger signal that activates the NLRP3 inflammasome and IL-1β secretion by bronchoalveolar fluid macrophages from asthmatic subjects.

Authors:  Elizabeth M Gordon; Xianglan Yao; Haitao Xu; William Karkowsky; Maryann Kaler; Or Kalchiem-Dekel; Amisha V Barochia; Meixia Gao; Karen J Keeran; Kenneth R Jeffries; Stewart J Levine
Journal:  J Allergy Clin Immunol       Date:  2019-03-11       Impact factor: 14.290

10.  Influence of APOE locus on poor prognosis of COVID-19.

Authors:  Juliana Carla Gomes Rodrigues; Pablo Pinto; Luciana Pereira Colares Leitão; Lui Wallacy Morikawa Souza Vinagre; Natasha Monte; Marianne Rodrigues Fernandes; André Salim Khayat; Paulo Pimentel de Assumpção; Ney Pereira Carneiro Dos Santos; Sidney Emanuel Batista Dos Santos
Journal:  Heliyon       Date:  2021-06-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.